http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 16 Jun 2026 11:10:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++CERT+++++++Caris+Life+Sciences%2C+++++++++++++++++/26652480.html si-local-file:///var/storage/secattach/20260616/26652480.html http://www.streetinsider.com/SEC+Filings/Form++CERT+++++++Caris+Life+Sciences%2C+++++++++++++++++/26652480.html Tue, 16 Jun 2026 11:10:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++CERT+++++++Caris+Life+Sciences%2C+++++++++++++++++/26652480.html si-local-file:///var/storage/secattach/20260616/26652480.html http://www.streetinsider.com/SEC+Filings/Form++CERT+++++++Caris+Life+Sciences%2C+++++++++++++++++/26652480.html Tue, 16 Jun 2026 11:10:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++8-A12B+++++Caris+Life+Sciences%2C+++++++++++++++++/26652346.html si-local-file:///var/storage/secattach/20260616/26652346.html http://www.streetinsider.com/SEC+Filings/Form++8-A12B+++++Caris+Life+Sciences%2C+++++++++++++++++/26652346.html Tue, 16 Jun 2026 10:47:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++8-A12B+++++Caris+Life+Sciences%2C+++++++++++++++++/26652346.html si-local-file:///var/storage/secattach/20260616/26652346.html http://www.streetinsider.com/SEC+Filings/Form++8-A12B+++++Caris+Life+Sciences%2C+++++++++++++++++/26652346.html Tue, 16 Jun 2026 10:47:00 -0400 CAI O.10953170 http://www.streetinsider.com/Corporate+News/Caris+Life+Sciences+dual-lists+on+NYSE+Texas+under+CAI+ticker/26651054.html <p>Caris Life Sciences (NASDAQ: CAI) announced that its common stock will be dual-listed on NYSE Texas effective June 17, 2026, while continuing to trade on the NASDAQ as its primary exchange. The stock will carry the same CAI ticker symbol on both exchanges.</p><p>The Irving, Texas-based company said the dual listing is intended to provide additional exposure to investors, particularly within Texas and the broader U.S. market.</p><p>"Establishing a dual listing on NYSE Texas reflects both our continued growth as a public company and our deep roots in Texas, including our headquarters and over 450 Caris employees in the state," said David http://www.streetinsider.com/Corporate+News/Caris+Life+Sciences+dual-lists+on+NYSE+Texas+under+CAI+ticker/26651054.html Tue, 16 Jun 2026 08:31:43 -0400 CAI http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 16, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4712171-1&amp;h=1113811457&amp;u=https%3A%2F%2Fwww.carislifesciences.com%2F&amp;a=Caris+Life+Sciences" target="_blank" rel="nofollow"><span value="NASDAQ-NMS:CAI" idsrc="xmltag.org" >Caris Life Sciences</span></a>® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on <chron>June 17, 2026</chron>, further expanding its presence in the public markets.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Dual+Listing+on+NYSE+Texas/26651015.html Tue, 16 Jun 2026 08:30:00 -0400 A.11423154 CAI O.03193857 O.10953170 http://www.streetinsider.com/Stock+Buybacks/Caris+Life+Sciences+authorizes+%24100+million+share+repurchase+program/26614763.html <p>Caris Life Sciences (NASDAQ: CAI) announced that its board of directors has authorized a share repurchase program for up to $100 million of the company's outstanding common stock.</p> <p>The Irving, Texas-based precision medicine company may repurchase shares through open market purchases, privately negotiated transactions, or other means, including trading plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Open market repurchases will follow applicable federal securities laws, including pricing and volume requirements of Rule 10b-18.</p> <p>The timing, manner, price and amount of repurchases will be determined at the company's discretion based on factors including market conditions, the http://www.streetinsider.com/Stock+Buybacks/Caris+Life+Sciences+authorizes+%24100+million+share+repurchase+program/26614763.html Mon, 08 Jun 2026 08:30:26 -0400 CAI O.10953170 http://www.streetinsider.com/Stock+Buybacks/Caris+Life+Sciences+authorizes+%24100+million+share+repurchase+program/26614763.html <p>Caris Life Sciences (NASDAQ: CAI) announced that its board of directors has authorized a share repurchase program for up to $100 million of the company's outstanding common stock.</p> <p>The Irving, Texas-based precision medicine company may repurchase shares through open market purchases, privately negotiated transactions, or other means, including trading plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Open market repurchases will follow applicable federal securities laws, including pricing and volume requirements of Rule 10b-18.</p> <p>The timing, manner, price and amount of repurchases will be determined at the company's discretion based on factors including market conditions, the http://www.streetinsider.com/Stock+Buybacks/Caris+Life+Sciences+authorizes+%24100+million+share+repurchase+program/26614763.html Mon, 08 Jun 2026 08:30:26 -0400 CAI O.10953170 http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that its Board of Directors has authorized a share repurchase program for up to <money>$100 million</money> of the Company's outstanding common stock.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS863020/Caris_Life_Sciences_Logo.jpg?id=OA2690183" title="Caris http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html Mon, 08 Jun 2026 08:30:00 -0400 CAI O.10953170 http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that its Board of Directors has authorized a share repurchase program for up to <money>$100 million</money> of the Company's outstanding common stock.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS863020/Caris_Life_Sciences_Logo.jpg?id=OA2690183" title="Caris http://www.streetinsider.com/Press+Releases/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html Mon, 08 Jun 2026 08:30:00 -0400 CAI O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that its Board of Directors has authorized a share repurchase program for up to <money>$100 million</money> of the Company's outstanding common stock.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS863020/Caris_Life_Sciences_Logo.jpg?id=OA2690183" title="Caris http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html Mon, 08 Jun 2026 08:30:00 -0400 CAI O.10953170 http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.tx.irving" idsrc="xmltag.org" >IRVING, Texas</location></span>, <span class="legendSpanClass"><chron>June 8, 2026</chron></span> /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Company"), a leading next-generation AI TechBio company and precision medicine pioneer, today announced that its Board of Directors has authorized a share repurchase program for up to <money>$100 million</money> of the Company's outstanding common stock.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> <img src="https://mmx.prnewswire.com/media/MS863020/Caris_Life_Sciences_Logo.jpg?id=OA2690183" title="Caris http://www.streetinsider.com/PRNewswire/Caris+Life+Sciences+Announces+Share+Repurchase+Program/26614753.html Mon, 08 Jun 2026 08:30:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Caris+Life+Sciences%2C++++++For%3A+Jun+04/26612087.html si-local-file:///var/storage/secattach/20260605/26612087.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Caris+Life+Sciences%2C++++++For%3A+Jun+04/26612087.html Fri, 05 Jun 2026 17:03:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Caris+Life+Sciences%2C++++++For%3A+Jun+04/26612087.html si-local-file:///var/storage/secattach/20260605/26612087.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Caris+Life+Sciences%2C++++++For%3A+Jun+04/26612087.html Fri, 05 Jun 2026 17:03:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+POSTE+GEORGE/26593495.html si-local-file:///var/storage/secattach/20260602/26593495.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+POSTE+GEORGE/26593495.html Tue, 02 Jun 2026 17:44:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+POSTE+GEORGE/26593495.html si-local-file:///var/storage/secattach/20260602/26593495.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+POSTE+GEORGE/26593495.html Tue, 02 Jun 2026 17:44:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+Knowles+Jonathan+Kenneth+Charles/26593489.html si-local-file:///var/storage/secattach/20260602/26593489.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+Knowles+Jonathan+Kenneth+Charles/26593489.html Tue, 02 Jun 2026 17:43:00 -0400 CAI O.10953170 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+Knowles+Jonathan+Kenneth+Charles/26593489.html si-local-file:///var/storage/secattach/20260602/26593489.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Caris+Life+Sciences%2C++++++For%3A+May+29++Filed+by%3A+Knowles+Jonathan+Kenneth+Charles/26593489.html Tue, 02 Jun 2026 17:43:00 -0400 CAI O.10953170